Narcotic Abuse

20 registered clinical trials studyying Narcotic Abuse.

Status	Trial	Sponsor	Phase
Completed	A Prospective Assessment of Opioid Utilization Post-operatively in Sports Orthopaedic Surgeries NCT03422211	St. Louis University	—
Completed	A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Op NCT02751762	Member Companies of the Opioid PMR Consortium	—
Terminated	Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic NCT02741076	Member Companies of the Opioid PMR Consortium	Phase 4
Completed	Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication NCT02660619	Member Companies of the Opioid PMR Consortium	—
Completed	An Observational Study to Develop Algorithms for Identifying Opioid Abuse and Addiction Based on Admin Claims NCT02667262	Member Companies of the Opioid PMR Consortium	—
Completed	A Quantitative Study to Assess the Construct Validity of the Prescription Opioid Misuse and Abuse Questionnair NCT02678507	Member Companies of the Opioid PMR Consortium	—
Completed	Study to Validate Coded Medical Terms Used to Identify Opioid-Related Overdose in Databases Used for PMR Study NCT02667197	Member Companies of the Opioid PMR Consortium	—
Completed	Cross-Sectional Study to Define and Validate "Doctor/Pharmacy Shopping" as Outcomes Suggestive of Abuse and/or NCT02668549	Member Companies of the Opioid PMR Consortium	—
Completed	A Qualitative Study to Assess the Content Validity of the Prescription Opioid Misuse and Abuse Questionnaire NCT02660606	Member Companies of the Opioid PMR Consortium	—
Completed	A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or NCT02667158	Member Companies of the Opioid PMR Consortium	—
Completed	Study to Eval Relation Btw Doctor/Pharmacy Shopping & Outcomes of Misuse, Diversion, Abuse, Addiction by Med R NCT02667210	Member Companies of the Opioid PMR Consortium	—
Completed	Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release NCT01595867	Pfizer	Phase 1
Completed	A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Voluntee NCT01530542	Pfizer	Phase 1
Completed	Aprepitant Effects on Oxycodone Response NCT00999544	Sharon Walsh	N/A
Unknown	Evaluation of Drug Utilization Patterns for Extended Release/Long Acting Opioids and Comparator Products NCT02925806	ER/LA Opioid REMS Program Companies (RPC)	—
Unknown	Evaluation of Changes in Prescribing Behavior of ER/LA Opioid Prescribers NCT02920762	ER/LA Opioid REMS Program Companies (RPC)	—
Unknown	Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers NCT02871232	ER/LA Opioid REMS Program Companies (RPC)	—
Unknown	ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner Databases NCT02897414	ER/LA Opioid REMS Program Companies (RPC)	—
Unknown	Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid Analgesics NCT02920775	ER/LA Opioid REMS Program Companies (RPC)	—
Unknown	ER/LA Opioid Surveillance for Emergency Department Visits and Hospitalizations for Overdose and Poisoning NCT02866266	ER/LA Opioid REMS Program Companies (RPC)	—